Clover Health Investments: 2027 Medicare Advantage ratings PPO 5, HMO 4.5

What happened Clover Health Investments, Corp. issued a press release on Oct 8, 2026, commenting on the Centers for Medicare & Medicaid Services release of its 2027 Star Ratings for the Company’s Medicare Advantage plans. CMS awarded the Company’s PPO MA plans 5 Stars and the Company’s HMO MA plan 4.5 Stars. The 2027 Star ratings affect payment year 2028. In light of the decision in Clover Insurance Company v. Department of Health & Human Services, Civ. A. No. 25-142 (S.D. Ga.) issued on May 27, 2026, which is on appeal, CMS calculated the Company’s PPO rating removing the 20 measures included in the court decision, awarding the PPO plans 5 Stars; with the 20 measures included, the PPO plans would have received 4.5 Stars.

Key details

• Press release dated Oct 8, 2026, was furnished as part of the Oct 8, 2026 Form 8-K (Item 7.01, Regulation FD disclosure).
• CMS 2027 Star ratings affect payment year 2028.
• PPO MA plans: 5 Stars (5 Stars after removing 20 measures; 4.5 Stars with the 20 measures included).
• HMO MA plan: 4.5 Stars.
• Court case: Clover Insurance Company v. Department of Health & Human Services, Civ. A. No. 25-142 (S.D. Ga.), decision issued May 27, 2026; the decision is on appeal.

Why it may matter The filing reports Item 7.01 (Regulation FD disclosure), which covers public disclosure of material information about the Company. This filing does not show why the insider traded or why the company acted.